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1 | BACKGROUND
The old adage, “What doesn't kill you makes you stronger” may at
times be offered as a platitude to those going through diagnosis and
treatment for cancer. The idea that traumatic or highly challenging life
experiences and the struggles that accompany them may eventually
lead someone towards positive changes in behaviour or life outlook
has been much explored in cancer survivorship studies, most com-
monly using the term “posttraumatic growth” (PTG).1 We propose
that there is a need for a focused future research agenda so that the
study of PTG translates into benefits for cancer survivors. As a first
step in forming that agenda, and to stimulate debate and further
enquiry, we suggest five key areas to be addressed.
1.1 | Terminology and definitions
PTG has been defined as an unplanned and unexpected emotional,
behavioural, or cognitive change which occurs after a life crisis and
struggle and following a period of reflection and rumination; it is both
a process and an outcome following trauma.1 The cancer experience
differs from an acute event such as an accident or natural disaster; it
is focused on the body and highly medicalised. Initial concerns may be
around diagnosis and prognosis, but later may (also) relate to treat-
ment experiences or ongoing sequelae. It is, therefore, difficult to
define both the nature of any cancer-related trauma and its
aftermath.
Cancer survivorship studies use various terms to describe PTG
(eg, “stress-related growth”, “perceived benefit”, “benefit-finding”).
This makes systematic identification and synthesis of the literature on
PTG extremely challenging. Moreover, it is unclear whether these
terms refer to the same construct(s). Where appropriate, researchers
should clearly reference the construct(s) being examined in their work
and how this/they is/are defined and interpreted. In addition, rigorous
scoping work would identify the range of terms used in cancer
survivorship research and where there may be inconsistencies.
1.2 | Measurement and determinants
Several scales have been used to measure PTG. Whether these are
multi-dimensional or (all) measure the same (single) overarching con-
struct of positive change remains unclear.2 The most commonly used
tool, the Post-Traumatic Growth Inventory (PTGI), has notable limita-
tions. The respondent is required to report their current outlook in
comparison with life pre-trauma, which may be challenging. Differ-
ences in scores between groups of cancer survivors have been
reported; it is unclear whether these differences are meaningful. It is
also unclear how cancer survivors' scores compare with others who
have experienced different traumas. Norm scores (ie, PTGI scores for
the general population) are unavailable. Uncertainties remain about
issues including test-retest reliability, scaling (eg, does a score of
80 represent twice as much growth as a score of 40?), and responsive-
ness to changed circumstances over time. It is unclear to what extent
the positive changes/growth people describe in qualitative studies are
reflected in scales, or whether the PTGI (and other scales) capture all
aspects of growth. There is no established cut-off to identify whether
growth has occurred or indication of what represents “clinical
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significance”. Assessment of measurement properties of available
instruments would help clarify how best to quantify PTG among
survivors.
Two systematic reviews have synthesised the literature on stud-
ies using scale measures to examine factors influencing PTG.3,4 Both
aimed to include studies with a focus on PTG but by necessity
searched using various terms and included published research using
several measures. Fairly consistent significant relationships between
PTG and constructs such as optimism and meaning-making were
found. Casselus-Grau et al. reported positive associations with hope
and gratitude and Shand et al with spirituality, religious coping, and
social support. This suggests that access to support and an ability to
construct meaning around the cancer experience is important. Beyond
this, there is a lack of consensus on which survivor characteristics,
clinical variables, and psychosocial factors are positively or negatively
associated with PTG. Cancer diagnosis and treatment may be life-
altering and result in various long term consequences for the individ-
ual, some visible or obvious to others (eg, scars, lymphoedema, com-
munication problems) and some requiring a considerable amount of
ongoing life adjustment. How might these consequences influence
PTG? There are also other known unknowns: for example, how resil-
ience, fear of recurrence or previous experiences influence an individ-
ual's ability to process their cancer experiences.
The quantitative evidence is largely cross-sectional, meaning that
directions of association between some variables (eg, measures of
hope, optimism) and PTG is uncertain. Little is known about when PTG
develops post-cancer, how it evolves over time, what influences tem-
poral trajectories, or the influence of supportive interventions (eg, spe-
cialist nursing, peer or psycho-oncological support). Large-scale
longitudinal studies starting (ideally) before confirmed diagnosis, and
including non-cancer comparators, would be valuable. These could use
analytical approaches which seek to shed light on causal pathways.
1.3 | Understanding pathways to growth
The route towards PTG for cancer survivors may be highly complex.
Several have questioned what might represent “genuine” PTG.
Tedeschi et al. address these concerns by suggesting that any self-
deceptive reports of positive change may be part of the process of
dealing with trauma and can be considered as rumination. Regarding
cancer, it would be valuable to better understand whether this type of
positive reframing forms part of the coping process, whether PTG is
simply a specific coping strategy, and/or whether other adaptive cop-
ing strategies can transform into embedded positive changes and,
hence, PTG.
Seiler and Jenewein offer a conceptual framework related to resil-
ience.5 They suggest there may be a direct pathway to PTG facilitated
by personality traits such as greater pre-existing levels of resilience
but that some cancer survivors may take a more indirect path, with
PTG facilitated by adjustment and positive reframing. Frameworks
such as this are currently not well supported by empirical data and
would benefit from deeper exploration of individuals' experiences of
change over time. Returning to the above definition of PTG,1 greater
focus is now needed on process(es) rather than outcome.
1.4 | Understanding potential corollaries of PTG
It is important to determine whether cancer survivors who report PTG
experience additional psychosocial (or other) benefits than those who
do not. Studies have tentatively suggested positive associations
between moderate-to-high PTG and health-related quality-of-life
(HRQoL)6 and PTG and psychological wellbeing.7 Better understand-
ing of these associations is of considerable importance, especially as
HRQoL is gaining recognition as an independent prognostic factor in
cancer.8
1.5 | Informing intervention development
If PTG does hold additional benefits for cancer survivors, the next nat-
ural step should be to determine whether it can be facilitated and
enabled. Guidance on intervention development points to a need to
review published evidence, draw on existing theories, understand the
context in which the intervention will be implemented, and involve
key stakeholders who may benefit.9 The formative evidence on PTG
determinants and pathways is currently insufficient to form a basis for
intervention planning. Filling the gaps is an essential precursor to
intervention design work, which should involve patients, carers and
Key Points
1. The study of post-traumatic growth (PTG) is a growing
field in cancer survivorship research. Greater clarity
regarding definitions and terminology around PTG is
needed to ensure relevant literature can be identified
and better understand the differences between closely
related constructs.
2. Consensus is required on what constitutes “meaningful”
PTG in cancer survivors and how it can be quantified.
3. Further qualitative research exploring what survivors
perceive as helping or hindering positive change post-
cancer would suggest possible pathways towards PTG.
4. Large-scale longitudinal quantitative studies, with non-
cancer comparators, would help better understand tem-
poral trajectories in PTG and whether health-related
quality-of-life and related outcomes are corollaries
of PTG.
5. A focused future research agenda, incorporating the
issues above, would help translate the study of PTG into
interventions that, if effective, may provide long-term
benefits for cancer survivors.
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potential service providers. Iterative refinement and optimisation
involving users will result in interventions ready to be tested in the
“real world”, initially in terms of acceptability and feasibility and
subsequently in terms of efficacy.
Importantly, any focus on PTG within interventions to support
cancer survivors does not mean that the negative consequences of
cancer should be disregarded or downplayed. PTG and associated ter-
minology should not be presented as an expected outcome following
cancer as this may lead to feelings of negativity or pressure10; the
focus should be on aspiration rather than expectation.
2 | CONCLUSIONS
Post-traumatic growth is a complex phenomenon. Better understand-
ing of how and when it is experienced, how to measure it, what influ-
ences its development and how any benefits might be enabled would
make a hugely valuable contribution to cancer research. A focus on
these key areas can lead towards more evidence-based long-term
support for survivors—working towards the goal that lives following
cancer are lives lived well.
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